Established in 2009, BioElpida, a CDMO based in Lyon France , has continuously expanded its expertise and know-how in the development and GMP manufacturing of preclinical and clinical batches for start-ups and biotech companies engaged in innovative therapies.

Our team of experts address biotherapies projects from late discovery to clinical phase 3 by offering flexible and tailor-made approaches in compliance with the regulatory framework.  Our services also include cell banking and liquid aseptic fill & finish.